Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

British Journal of Cancer
L NolanS J Crabb

Abstract

Histone deacetylase inhibitors have progressed rapidly from the laboratory to clinical testing. This review highlights the promising data for their combination with a wide range of established and novel anticancer agents and discusses the mechanisms that underpin these interactions.

References

Nov 4, 2000·Nature Genetics·S C TsaiE Seto
Apr 2, 2003·The Journal of Cell Biology·Gary D KaoTim J Yen
Aug 16, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lin-Feng Chen, Warner C Greene
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin-Yan PeiSteven Grant
May 4, 2005·Cancer Research·Douglas C MarchionPamela N Munster
Jun 2, 2005·Leukemia Research·Hui YangGuillermo Garcia-Manero
Jun 21, 2005·The International Journal of Biochemistry & Cell Biology·Lucia AltucciHinrich Gronemeyer
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anupama MunshiRaymond E Meyn
Aug 27, 2005·Cell Cycle·Bonnie Graham, Spencer B Gibson
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Purva BaliKapil Bhalla
Jan 16, 2007·Cancer Biology & Therapy·Alessandra ValentiniSergio Bernardini
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela MünsterAdil Daud
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Girija DasmahapatraSteven Grant

❮ Previous
Next ❯

Citations

Sep 24, 2009·Haematologica·Sean H LimMark S Cragg
Oct 1, 2009·Epigenomics·Francesco CreaWilliam L Farrar
Aug 7, 2010·Expert Opinion on Investigational Drugs·Paul A Marks
Apr 1, 2011·Expert Opinion on Drug Discovery·Florian Thaler, Saverio Minucci
Jun 6, 2015·International Journal of Oncology·Pyoung Rak ChoiNam Deuk Kim
Mar 24, 2012·Cancer Biology & Therapy·Jhanelle GrayAlberto Chiappori
May 22, 2009·Journal of Cellular Biochemistry·P A Marks, W-S Xu
Oct 30, 2012·Molecular Oncology·Angela NebbiosoLucia Altucci
Nov 13, 2012·Molecular Oncology·Maria NewNicholas B La Thangue
Oct 12, 2018·Reproduction, Fertility, and Development·Bingyue ZhangPeiqing Cong
May 4, 2010·Anti-cancer Drugs·Katarina Sebova, Ivana Fridrichova
Sep 3, 2019·Current Topics in Medicinal Chemistry·Hao HeLei Zheng
Apr 21, 2017·Oncotarget·Laura BrandoliniAnnamaria Cimini
Oct 3, 2018·Future Science OA·Aline A Zuma, Wanderley de Souza
Feb 2, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shoumin ZhuWael El-Rifai
Aug 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toshio ShimizuAnthony W Tolcher
Feb 27, 2021·Frontiers in Cell and Developmental Biology·Natália Lourenço de FreitasChristiane P Soares
Jun 3, 2021·International Journal of Molecular Sciences·Qiting ZhangBin Zhang
Sep 24, 2010·Journal of Medicinal Chemistry·Oula C MansourSuzanne M Cutts

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
acetylation
ubiquitination
nuclear translocation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.